Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI)

Chemical Research in Toxicology

Volumn 18, Issue 1, 2005, Pages 3-11

  Zhitkovich, Anatoly ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM;

APOPTOSIS; AQUEOUS SOLUTION; CELL DEATH; CELL DIVISION; CHEMICAL STRUCTURE; CLONOGENESIS; CROSS LINKING; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA MODIFICATION; EXCISION REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTAGENICITY; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHROMIUM; DNA ADDUCTS; DNA DAMAGE; HUMANS; MUTAGENS;

EID: 12144270899     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049774+     Document Type: Review

References (87)

1. Agency for Toxic Substances and Disease Registry (1993) Toxicological Profile for Chromium, U.S. Department of Health and Human Services, Washington, DC.
2. International Agency for Research on Cancer (1990) Chromium, nickel and welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, pp 49-256, World Health Organization, Lyon, France.
3. Case, C. P., Langkamer, V. G., James C., Palmer, M. P., Kemp A. J., Heap P. F., and Solomon L. (1994). Widespread dissemination of metal debris from implants. J. Bone Joint Surg. 76B, 701-711.
4. Merritt, K., and Brown, S. A. (1995) Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J. Biomed. Mater. Res. 29, 627-633.
5. Langardt, S. (1990) One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17, 189-215.
6. Sorahan, T., Burges, D. C., Hamilton, L., and Harrington, J. M. (1998) Lung cancer mortality in nickel/chromium platers, 1946-95. Occup. Environ. Med. 55, 236-242.
7. Gibb, H. J., Lees, P. S. J., Pinsky, P. F., and Rooney, B. C. (2000) Lung cancer among workers in chromium chemical production. Am. J. Ind. Med. 38, 115-126.
8. Barchowsky, A., and O'Hara, K. A. (2003) Metal-induced cell signaling and gene activation in lung diseases. Free Radical Biol. Med. 34, 1130-1135.
9. Zhitkovich, A. (2002) Chromium: exposure, toxicity and biomonitoring approaches. In Biomarkers of Environmentally Associated Disease: Technologies, Concepts, and Perspectives (Wilson, S. H., and Suk, W. A., Eds.) pp 269-287, CRC Press LLC, New York.
10. Ishikawa, Y., Nakagawa, K., Satoh, Y., Kitagawa, T., Sugano, H., Hirano, T., and Tsuchiya, E. T. (1994) Characteristics of chromate workers' cancers, chromium lung deposition and precancerous lesions: An autopsy study. Br. J. Cancer 70, 160-166.
11. Biedermann, K. A., and Landolph, J. R. (1990) Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis and anchorage independence in diploid human fibroblasts. Cancer Res. 50, 7835-7842.
12. De Flora, S., Bagnasco, M., Serra D., and Zanacchi, P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res. 238, 99-172.
13. Kuo, H. W., Lai, J. S., and Lin, T. I. (1997) Nasal septum lesions and lung function in workers exposed to chromic acid in electroplating factories. Int. Arch. Occup. Environ. Health 70, 272-276.
14. Bose, R. N., Moghaddas, S., and Gelerinter, E. (1992) Long-lived chromium(IV), chromium(V) metabolites in the chromium(VI)-glutathione reaction: NMR, ESR, HPLC, and kinetic characterization. Inorg. Chem. 31, 1987-1994.
15. Stearns, D. M., and Wetterhahn, K. E. (1994) Reaction of Cr(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem. Res. Toxicol. 7, 219-230.
16. Lay, P. A., and Levina, A. (1998) Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: Implications for chromium-induced genotoxicities. J. Am. Chem. Soc. 120, 6704-6714.
17. Dillon, C. T., Lay, P. A., Cholewa, M., Legge, G. J., Bonin, A. M., Collins, T. J., Kostka, K. L., and Shea-McCarthy, G. (1997) Microprobe X-ray absorption spectroscopic determination of the oxidation state of intracellular chromium following exposure of V79 Chinese hamster lung cells to genotoxic chromium complexes. Chem. Res. Toxicol. 10, 533-535.
18. O'Brien, T. J., Ceryak, S., and Patierno, S. R. (2003) Complexities of chromium carcinogenesis: Role of cellular response, repair and recovery mechanisms. Mutat. Res. 533, 3-36.
19. Salnikow, K., Zhitkovich, A., and Costa, M. (1992) Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis 13, 2341-2346.
20. Liu, S., and Dixon, K. (1996) Induction of mutagenic DNA damage by chromium(VI) and glutathione. Environ. Mol. Mutagen. 28, 71-79.
21. Krepkiy, D., Antholine, W. E., Myers, C., and Petering, D. H. (2001) Model reactions of Cr (VI) with DNA mediated by thiol species. Mol. Cell. Biochem. 222, 213-219.
22. Zhitkovich, A., Messer, J., and Shrager, S. (2000) Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem. Res. Toxicol. 13, 1114-1124.
23. Cieslak-Golonka, M. (1995) Toxic and mutagenic effects of chromium(VI). A review. Polyhedron 15, 3667-3689.
24. Theopold, K. H. (1997) Chromium: Inorganic and coordination chemistry. In Encyclopedia of Inorganic Chemistry (King, B. R., Ed.) Vol. 2, pp 666-678, John Wiley & Sons, New York.
25. Sehlmeyer, U., Hetchtenberg, S., Klyszcz, H., and Beyersmann, D. (1990) Accumulation of chromium in Chinese hamster V79-cells and nuclei. Arch. Toxicol. 64, 506-508.
26. Alexander, J., and Aaseth, J. (1995) Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier. Analyst 120, 931-933.
27. Connett, P. H., and Wetterhahn, K. E. (1983) Metabolism of the carcinogen chromate by cellular constituents. Struct. Bonding 54, 93-124.
28. Connett, P. H., and Wetterhahn, K. E. (1986) Reaction of chromium(VI) with thiols: pH dependence of chromium(VI) thio ester formation. J. Am. Chem. Soc. 108, 1842-1847.
29. De Flora, S., Camoirano, A., Bagnasco, M., Bennicelli, C., Corbett, G. E., and Kerger, B. D. (1997) Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 18, 531-537.
30. De Flora, S. (2000) Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 21, 533-541.
31. Mirsalis, J. C., Hamilton, C. M., O'Loughlin, K. G., Paustenbach, D. J., Kerger, B. D., and Patierno, S. (1996) Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays. Environ. Mol. Mutagen. 28, 60-63.
32. Costa, M. (1997) Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit. Rev. Toxicol. 27, 431-442.
33. Sutherland, J. E., Zhitkovich, A., Kluz, T., and Costa, M. (2000) Rats retain chromium in tissues following chronic ingestion of drinking water containing 3 or 10 ppm hexavalent chromium. Biol. Trace Elem. Res. 74, 41-53.
34. Grace, M. R., and Spiccia, L. (1991) Early stages of the hydrolysis of chromium(III) in aqueous solution. 1. Kinetics of intermolecular interconversion between singly- and doubly bridged dimers. Polyhedron 10, 619-628.
35. Saleh, F. Y., Mbamalu, G. E., Jaradat, Q. H., and Brungardt, C. E. (1996) Ion chromatography-photodiode array UV-visible detection of Cr(III) hydrolytic polymerization products in pure and natural waters. Anal. Chem. 68, 740-745.
36. Stewart, I. I., and Olesik, J. W. (2000) Investigation of Cr(III) hydrolytic polymerisation products by capillary electrophoresis-inductively coupled plasma-mass spectrometry. J. Chromatogr. A 872, 227-246.
37. Zhitkovich, A., Voitkun, V., and Costa, M. (1996) Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: Importance of trivalent chromium and the phosphate group. Biochemistry 35, 7275-7282.
38. Cieslak-Golonka, M., Raczko, M., and Staszak, Z. (1992) Synthesis, spectroscopic and magnetic studies of chromium(III) complexes isolated from in vitro reduction of the chromium(VI) ion with the main cellular reductants ascorbic acid, cysteine and glutathione. Tetrahedron 19, 2549-2555.
39. O'Brien, T., Mandel, G. H., Pritchard, D. E., and Patierno, S. R. (2002) Critical role of chromium(Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41, 12529-12537.
40. Kortenkamp, A., Curran, B., and O'Brien, P. (1992) Defining conditions for the efficient in vitro cross-linking of proteins to DNA by chromium(III) compounds. Carcinogenesis 13, 307-308.
41. Coogan, T. P., Squibb, K. S., Motz, J., Kinney, P. L., and Costa, M. (1991) Distribution of chromium within cells of the blood. Toxicol. Appl. Pharmacol. 108, 157-166.
42. Gao, M., Levy, L. S., Braithwaite, R. A., and Brown, S. S. (1993) Monitoring of total chromium in rat fluids and lymphocytes following intratracheal administration of soluble trivalent or hexavalent chromium compounds. Hum. Exp. Toxicol. 12, 377-382.
43. Sipowicz, M. A., Anderson, L. M., Utermahlen, W. E., Jr., Issaq, H. J., and Kasprzak, K. S. (1997) Uptake and tissue distribution of chromium(III) in mice after a single intraperitoneal or subcutaneous administration. Toxicol. Lett. 93, 9-14.
44. Suzuki, Y., and Fukuda, K. (1990) Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol. 64, 169-176.
45. Standeven, A. M., and Wetterhahn, K. E. (1991) Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogenesis 12, 1733-1737.
46. Standeven, A. M., and Wetterhahn, K. E. (1992) Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis 13, 1319-1324.
47. Quievryn, G., Goulart, M., Messer, J., and Zhitkovich, A. (2001) Reduction of Cr(VI) by cysteine: Significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol. Cell. Biochem. 222, 107-118.
48. Quievryn, G., Peterson, E., Messer, J., and Zhitkovich, A. (2003) Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 42, 1062-1070.
49. Goodgame, D. M. L., and Joy, M. A. (1987) EPR study of the Cr-(V) and radical species produced in the reduction of Cr(VI) by ascorbate. Inorg. Chim. Acta 135, 115-118.
50. O'Brien, P., Wang, G., and Wyatt, P. B. (1992) Studies on the kinetics of the reduction of chromate by glutathione and related thiols. Polyhedron 11, 3211-3216.
51. Kwong, D. W. J., and Pennington, D. E. (1984) Stoichiometry, kinetics, and mechanisms of the chromium(VI) oxidation of L-cysteine. Inorg. Chem. 23, 2538-2532.
52. Zhitkovich, A., Voitkun, V., and Costa, M. (1995) Glutathione and free amino acids form stable adducts with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 16, 907-913.
53. Quievryn, G., Messer, J., and Zhitkovich, A. (2002) Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry 41, 3156-3167.
54. Salnikow, K., Donald, S. P., Bruick, R. K., Zhitkovich, A., Phang, J. M., and Kasprzak, K. S. (2004) Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279, 40337-40344.
55. Costa, M. (1990) Analysis of DNA-protein complexes induced by chemical carcinogens. J. Cell. Biochem. 92, 127-135.
56. Costa, M., Zhitkovich, A., Gargas, M., Paustenbach, D., Finley, B., Kuykendall, J., Billings, R., Carlson, T. J., Wetterhahn, K., Xu, J., Patierno, S., and Bogdanffy, M. (1996) Interlaboratory validation of a new assay for DNA-protein cross-links. Mutat. Res. 369, 13-21.
57. Hamilton, J. W., and Wetterhahn, K. E. (1986) Chromium (VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis 7, 2085-2088.
58. Zhitkovich, A., and Costa, M. (1992) A simple, sensitive assay to detect DNA-protein-cross-links in intact cells and in vivo. Carcinogenesis 13, 1485-1489.
59. Zhitkovich, A., Voitkun, V., Kluz, T., and Costa, M. (1998) Utilization of DNA-protein cross-links as a biomarker of chromium exposure. Environ. Health Perspect. 106 (Suppl. 4), 969-974.
60. Quievryn, G., and Zhitkovich, A. (2000) Loss of DNA-protein crosslinks from formaldehyde-exposed cells occurs through spontaneous hydrolysis and an active repair process linked to proteasome function. Carcinogenesis 21, 1573-1580.
61. Costa, M., Zhitkovich, A., and Toniolo, P. (1993) DNA-protein cross-links in welders: Molecular implications. Cancer Res. 53, 460-463.
62. Taioli, E., Zhitkovich, A., Kinney, P., Udasin, I., Toniolo, P., and Costa, M. (1995) Increased DNA-protein cross-links in lymphocytes of residents living in chromium contaminated areas. Biol. Trace Elem. Res. 50, 175-180.
63. Zhitkovich, A., Lukanova, A., Popov, T., Taioli, E., Cohen, H., Costa, M., and Toniolo, P. (1996) DNA-protein cross-links in peripheral lymphocytes of individuals exposed to hexavalent chromium compounds. Biomarkers 1, 86-93.
64. Werfel, U., Langen, V., Eickhoff, I., Schoonbrood, J., Vahrenholtz, C., Brauksiepe, A., Popp, W., and Norpoth, K. (1998) Elevated DNA single-strand breakage frequencies in lymphocytes of welders exposed to chromium and nickel. Carcinogenesis 19, 413-418.
65. Miller, C. A., 3rd, and Costa, M. (1989) Analysis of proteins crosslinked to DNA after treatment of cells with formaldehyde, chromate, and cis-diamminedichloroplatinum(II). Mol. Toxicol. 2, 11-26.
66. Mattagajasingh, S. N., and Misra, H. P. (1999) Analysis of EDTA-chelatable proteins from DNA-protein cross-links induced by a carcinogenic chromium(VI) in cultured intact human cells. Mol. Cell. Biochem. 199, 149-162.
67. Voitkun, V., and Zhitkovich, A. (1999) Analysis of DNA-protein cross-linking activity of malondialdehyde in vitro. Mutat. Res. 424, 97-106.
68. Dizdaroglu, M., Gajewski, E., Reddy, P., and Margolis, S. A. (1989) Structure of a hydroxyl radical induced DNA-protein cross-link involving thymine and tyrosine in nucleohistone. Biochemistry 28, 3625-3629.
69. Bridgewater, L. C., Manning, F. C., and Patierno, S. R. (1994) Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand cross-linking. Carcinogenesis 15, 2421-2427.
70. O'Brien, T., Xu, J., and Patierno, S. R. (2001) Effects of glutathione on chromium-induced DNA cross-linking and DNA polymerase arrest. Mol. Cell. Biochem. 222, 173-182.
71. Zhitkovich, A., Quievryn, G., Messer, J., and Motylevich, Z. (2002) Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Environ. Health Perspect. 110 (Suppl. 5), 729-731.
72. Snow, E. T., and Xu, L.-S. (1991) Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry 30, 11238-11245.
73. Bridgewater, L. C., Manning, F. C., Woo, E. S., and Patierno, S. R. (1994) DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinog. 9, 122-133.
74. Bridgewater, L. C., Manning, F. C., and Patierno, S. R. (1998). Arrest of replication by mammalian DNA polymerases α and β caused by chromium-DNA lesions. Mol. Carcinog. 23, 201-206.
75. Voitkun, V., Zhitkovich, A., and Costa, M. (1998) Cr(III)-mediated cross-links of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26, 2024-2030.
76. Zhitkovich, A., Song, Y., Quievryn, G., and Voitkun, V. (2001) Nonoxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40, 549-560.
77. Reynolds, M., Peterson, E., Quievryn, G., and Zhitkovich, A. (2004) Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem. 279, 30419-30424.
78. Chen, J., and Thilly, W. G. (1994) Mutational spectrum of chromium(VI) in human cells. Mutat. Res. 323, 21-27.
79. De Silva, I. U., McHugh, P. J., Clingen, P. H., and Hartley, J. A. (2000) Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol. 20, 7980-7990.
80. Dronkert, M. L., and Kanaar, R. (2001) Repair of DNA interstrand cross-links. Mutat. Res. 486, 217-247.
81. Larkworthy, L. F., Nolan, K. B., and O'Brien, P. (1988). Chromium. In Comprehensive Coordination Chemistry (Wilkinson, G., Ed.) Vol. 3, pp 699-969, Pergamon Press, New York.
82. Meister, A. (1994) Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269, 9397-9400.
83. Molyneux, M. J., and Davies, M. J. (1995) Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium-(VI)-derived species: Implications for chromium carcinogenesis. Carcinogenesis 16, 875-882.
84. Levina, A., Lay, P. A., and Dixon, N. E. (2001) Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro. Chem. Res. Toxicol. 14, 946-950.
85. Meester de, P., Hodgson, D. J., Freeman, H. C., and Moore, C. J. (1977) Tridentate coordination by the L-cysteine dianion. Crystal and molecular structure of sodium bis(L-cysteinato)chromate(III) dihydrate. Inorg. Chem. 16, 1494-1498.
86. Madafiglio, K., Manning, T. M., Murdoch, C. M., Tulip, W. R., Cooper, M. K., Hambley, T. W., and Freeman, H. C. (1990) Three chromium(III) complexes with mixed amino acid ligands: (L-cysteinato)-(L-histidinato)chromium(III) 3·5-hydrate, (L-aspartato)(L-histidinato)chromium(III) 1·5-hydrate and bis(DL-histidinato)chromium(III) chloride 4·2 hydrate. Acta Crystallogr. C46, 554-561.
87. Peterson, E., Reynolds, M., Messer, J., and Zhitkovich, A. (2003) Mismatch repair mediates toxicity of Cr-DNA adducts: Selection for mismatch repair deficiency as a new model of chromium(VI) carcinogenesis. Proc. Am. Assoc. Cancer Res. 44, 98.